In a mid-stage study, 13 of 15 patients who received Soliris did not require further treatment for aHUS. Based on some back-of-the-envelope math based on the incidence of aHUS in France and Italy, Sanford C.
Rachel Bennett from Exeter, whose son Felix was diagnosed with aHUS at six months, said Eculizumab was "incredible" and had given him a normal childhood for the first time at the age of nearly four.